HuGE Literature Finder
Records
1
-
10
| Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma. Molecular carcinogenesis 2023 1 . Patel Krupal B, Padhya Tapan A, Huang Jinyong, Hernandez-Prera Juan C, Li Tingyi, Chung Christine H, Wang Liang, Wang Xuefe |
| PCDH17 is regulated by methylation of DNMT3B and affects the malignant biological behavior of HCC through EMT. Experimental cell research 2022 6 418 (1): 113245. Liu Yan, Zhang Yudi, Du Di, Gu Xue, Zhou Shi |
| Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma. Clinical chemistry and laboratory medicine 2020 3 58 (8): 1332-1340. Baranova Ivana, Kovarikova Helena, Laco Jan, Sedlakova Iva, Vrbacky Filip, Kovarik Dalibor, Hejna Petr, Palicka Vladimir, Chmelarova Marce |
| Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma. Cancer management and research 2019 3 11 1601-1613. He Ya, Wang Zhihai, Liu Chuan, Gong Zhitao, Li Yanshi, Lu Tao, Hu Guoh |
| Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers. Genes, chromosomes & cancer 2018 Mar . Wolff Roger K, Hoffman Michael D, Wolff Erica C, Herrick Jennifer S, Sakoda Lori C, Samowitz Wade S, Slattery Martha |
| Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma. Cancer biomarkers : section A of Disease markers 2018 7 23 (1): 125-133. Baranova Ivana, Kovarikova Helena, Laco Jan, Dvorak Ondrej, Sedlakova Iva, Palicka Vladimir, Chmelarova Marce |
| Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation. Molecular carcinogenesis 2018 3 57 (7): 878-885. Byzia Ewa, Soloch Natalia, Bodnar Magdalena, Szaumkessel Marcin, Kiwerska Katarzyna, Kostrzewska-Poczekaj Magdalena, Jarmuz-Szymczak Malgorzata, Szylberg Lukasz, Wierzbicka Malgorzata, Bartochowska Anna, Kalinowicz Ewelina, Grenman Reidar, Szyfter Krzysztof, Marszalek Andrzej, Giefing Maci |
| An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese. Oncotarget 2015 12 7 (3): 2754-64. Wang Yongqiang, Yu Yuan, Ye Rui, Zhang Duo, Li Qiaoling, An Dan, Fang Lu, Lin Youcheng, Hou Yong, Xu Abai, Fu Yu, Lu Wei, Chen Xin, Chen Mingwei, Zhang Meng, Jiang Huiling, Zhang Chuanxia, Dong Pei, Li Chong, Chen Jun, Yang Guosheng, Liu Chunxiao, Cai Zhiming, Zhou Fangjian, Wu So |
| Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma. Medical science monitor : international medical journal of experimental and clinical research 2015 21 2870-6. Lin Ying-Li, Gui Shi-Liang, Guo Hong, Ma Jian-Guo, Li Wen-Pi |
| Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis 2010 3 31 (6): 1027-36. Haruki Shigeo, Imoto Issei, Kozaki Ken-ichi, Matsui Takeshi, Kawachi Hiroshi, Komatsu Shuhei, Muramatsu Tomoki, Shimada Yutaka, Kawano Tatsuyuki, Inazawa Joh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: